News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,956 Results
Type
Article (1942)
Company Profile (2)
Press Release (71012)
Section
Business (21481)
Career Advice (9)
Deals (4553)
Drug Development (8166)
FDA (1804)
Job Trends (801)
News (37045)
Policy (3561)
Tag
Academia (97)
Accelerated approval (4)
Allergies (19)
Alliances (8170)
ALS (15)
Alzheimer's disease (171)
Antibody-drug conjugate (ADC) (97)
Approvals (1940)
Artificial intelligence (29)
Autoimmune disease (26)
Automation (1)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (77)
Biotechnology (5)
Bladder cancer (30)
Brain cancer (6)
Breast cancer (58)
Cancer (581)
Cardiovascular disease (21)
Career advice (9)
CAR-T (12)
CDC (1)
Cell therapy (53)
Cervical cancer (5)
Clinical research (7585)
Collaboration (311)
Compensation (21)
Complete response letters (6)
COVID-19 (198)
C-suite (83)
Cystic fibrosis (7)
Data (739)
Depression (15)
Dermatology (10)
Diabetes (35)
Diagnostics (637)
Digital health (6)
Drug discovery (38)
Drug pricing (1)
Duchenne muscular dystrophy (36)
Earnings (8147)
Events (7504)
Executive appointments (69)
FDA (2254)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (142)
Gene editing (6)
Generative AI (1)
Gene therapy (36)
GLP-1 (75)
Government (240)
Grass and pollen (1)
Guidances (39)
Healthcare (1090)
HIV (6)
Huntington's disease (2)
IgA nephropathy (20)
Immunology and inflammation (6)
Immuno-oncology (11)
Indications (19)
Infectious disease (222)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (36)
IPO (1641)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (953)
Liver cancer (19)
Longevity (3)
Lung cancer (105)
Lymphoma (42)
Manufacturing (117)
MASH (17)
Medical device (1166)
Medtech (1181)
Mergers & acquisitions (3092)
Metabolic disorders (94)
mRNA (7)
Multiple sclerosis (19)
NASH (1)
Neurodegenerative disease (31)
Neuropsychiatric disorders (7)
Neuroscience (310)
NextGen: Class of 2026 (219)
Non-profit (63)
Obesity (29)
Opinion (1)
Ovarian cancer (33)
Pain (18)
Pancreatic cancer (24)
Parkinson's disease (44)
Partnered (3)
Patents (66)
Patient recruitment (59)
Peanut (1)
People (5158)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (2047)
Phase 2 (3210)
Phase 3 (2859)
Pipeline (1009)
Policy (1)
Postmarket research (241)
Preclinical (707)
Press Release (2)
Prostate cancer (22)
Radiopharmaceuticals (24)
Rare diseases (75)
Real estate (606)
Regulatory (2967)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (2)
RSV (3)
Schizophrenia (20)
Series A (28)
Series B (22)
Service/supplier (1)
Sickle cell disease (7)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (423)
Stomach cancer (3)
Supply chain (12)
Vaccines (45)
Venture capital (7)
Weight loss (13)
Women's health (7)
Date
Today (5)
Last 7 days (82)
Last 30 days (298)
Last 365 days (2802)
2026 (1138)
2025 (2688)
2024 (3256)
2023 (3821)
2022 (7021)
2021 (6379)
2020 (5876)
2019 (3866)
2018 (3013)
2017 (3562)
2016 (3172)
2015 (4031)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (4)
Arizona (13)
Arkansas (1)
Asia (22146)
Australia (2472)
California (751)
Canada (442)
China (445)
Colorado (5)
Connecticut (23)
Delaware (7)
Europe (13308)
Florida (79)
Georgia (14)
Illinois (38)
India (47)
Indiana (20)
Japan (299)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (116)
Massachusetts (581)
Michigan (9)
Minnesota (35)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (2)
New Jersey (438)
New York (266)
North Carolina (111)
Northern California (317)
Ohio (6)
Oregon (1)
Pennsylvania (137)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (366)
Tennessee (1)
Texas (59)
United States (2827)
Utah (27)
Virginia (53)
Washington D.C. (3)
Washington State (57)
Wisconsin (7)
72,956 Results for "compugen ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
·
2 min read
Compugen to Present at Upcoming Antibody Industrial Symposium
Compugen Ltd. today announced that Pierre Ferré, Ph.D, SVP, Preclinical Development and Corporate Operations, Compugen will present a case study on clinical dose selection for TIGIT monospecific and bispecific antibodies at the Antibody Industrial Symposium taking place June 20-21, 2024, Montpellier, France.
June 17, 2024
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Results of the Annual General Meeting
May 4, 2026
·
6 min read
Business
Compugen Appoints David Silberman as Chief Financial Officer
Compugen Ltd. today announced the appointment of David Silberman as its new Chief Financial Officer effective August 15, 2024, taking over from Alberto Sessa who will depart Compugen on the same day.
May 15, 2024
·
3 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May 15, 2026
·
3 min read
Press Releases
BYT Holdings Ltd. Anticipates Failure-to-File Cease Trade Order
April 30, 2026
·
3 min read
Business
Compugen Reports First Quarter 2024 Results
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 20, 2024
·
11 min read
Press Releases
Faron Pharmaceuticals Ltd: Director Dealing
March 19, 2026
·
3 min read
1 of 7,296
Next
